Public willingness to take a vaccine or drug under emergency use authorization during the 2009 H1N1 pandemic

Biosecurity and Bioterrorism

Volumn 7, Issue 3, 2009, Pages 275-290

  Quinn, Sandra Crouse ^a   Kumar, Supriya ^a   Freimuth, Vicki S ^c   Kidwell, Kelley ^a   Musa, Donald ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; EPIDEMIC; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MIDDLE AGED; PATIENT ATTITUDE; QUESTIONNAIRE; UNITED STATES; VIROLOGY;

ADOLESCENT; ADULT; AGED; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

SUIDAE;

EID: 70350139980     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2009.0041     Document Type: Article

References (57)

1. World Health Organization. Transcript of statement by Margaret Chan, Director General of the World Health Organization. June 11th 2009. http:==www.who.int=media centre=influenzaAH1N1-presstranscript-20090611.pdf. Accessed September 11, 2009.
2. U.S. Centers for Disease Control and Prevention. Novel H1N1 Flu Situation Update. August 6, 2009, 4:00 PM ET. http:==www.cdc.gov=h1n1flu=update.htm. Accessed September 11, 2009.
3. U.S. Centers for Disease Control and Prevention. Novel H1N1 U.S. Deaths, By Age Group. 2009. http:==www.cdc. gov=h1n1flu=surveillanceqa.htm#12. Accessed September 11, 2009.
4. U.S. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009;58(RR-8):26.
5. U.S. Food and Drug Administration. Guidance Emergency Use Authorization of Medical Products. 2007. http:==www. fda.gov=RegulatoryInformation=Guidances= ucm125127.htm. Accessed September 11, 2009.
6. Nightingale SL, Prasher JM, Simonson S. Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis 2007;13(7):1046-1051.
7. Courtney B. FDA Emergency Use Authorizations (EUAs): what are they and what do they mean for the H1N1 swine flu response? Biosecur Bioterror 2009;7(2):211-213.
8. U.S. Centers for Disease Control and Prevention. CDC H1N1 Vaccination Planning Q & A. June 25, 2009. http:==www.health.state.nm.us=FLU=seasonal= DOCS=H1N1- Vaccination-Planning-QA%206-25-09-v1%202.pdf. Accessed September 11, 2009.
9. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization. An online course developed by the Food and Drug Administration and Centers for Disease Control and Prevention. 2009. http:==www.bt.cdc.gov= training=eua=index.html. Accessed September 11, 2009.
10. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization (EUA) of Medical Products and Devices. 2009. http:==www.cdc.gov= h1n1flu=eua=. Accessed September 11, 2009.
11. U.S. Food and Drug Administration. FDA authorizes emergency use of another test for 2009 H1N1 influenza virus [press release]. July 24, 2009. http:==www.fda.gov=News Events=Newsroom=PressAnnouncements=ucm173543.htm. Accessed September 11, 2009.
12. President's Council of Advisors on Science and Technology. Report to the President on U.S. Preparations for 2009 H1N1 Influenza. August 7, 2009. http:==www.whitehouse.gov= asset.aspx?AssetId=2544 Accessed September 11, 2009.
13. Quinn SC, Thomas T, Kumar S. The anthrax vaccine and research: reactions from postal workers and public health professionals. Biosecur Bioterror 2008;6(4):321-333.
14. Covello V, Sandman PM. Risk communication: evolution and revolution. In: A. Wolbarst, ed. Solutions to an Environment in Peril. Baltimore: Johns Hopkins University Press; 2001:164-178.
15. Paek HJ, Hilyard K, Freimuth VS, Barge JK, Mindlin M. Public support for government actions during a flu pandemic: lessons learned from a statewide survey. Health Promot Pract 2008;9(4 Suppl):60S-72S.
16. Blanchard JC, Haywood Y, Stein BD, Tanielian TL, Stoto M, Lurie N. In their own words: lessons learned from those exposed to anthrax. Am J Public Health 2005;95(3):489-495.
17. Gursky E, Inglesby TV, O'Toole T. Anthrax 2001: observations on the medical and public health response. Biosecur Bioterror 2003;1(2):97-110.
18. Joellenbeck LM, Hernandez LM. The Institute of Medicine's independent scientific assessment of Gulf War health issues. Mil Med 2002;167(3):186-190.
19. North CS, Pollio DE, Pfefferbaum B, et al. Concerns of Capitol Hill staff workers after bioterrorism: focus group discussions of authorities' response. J Nerv Ment Dis 2005; 193(8):523-527. (Pubitemid 41140939)
20. Quinn S, Thomas T, McAllister C. Lessons from the 2001 anthrax attack: a conceptual model for crisis and emergency risk communication. In: Seeger M, Sellnow T, Ulmer R, eds. Crisis Communication and the Public Health. Cresskill, NJ: Hampton Press; 2008:23-42.
21. Quinn SC, Thomas T, McAllister C. Postal workers' perspectives on communication during the anthrax attack. Biosecur Bioterror 2005;3(3):207-215.
22. Stein BD, Tanielian TL, Ryan GW, Rhodes HJ, Young SD, Blanchard JC. A bitter pill to swallow: nonadherence with prophylactic antibiotics during the anthrax attacks and the role of private physicians. Biosecur Bioterror 2004;2(3): 175-185.
23. Covello VT, Peters RG, Wojtecki JG, Hyde RC. Risk communication, the West Nile virus epidemic, and bioterrorism: responding to the communication challenges posed by the intentional or unintentional release of a pathogen in an urban setting. J Urban Health 2001;78(2):382-391.
24. Ratzan SC. Communicating risk: from crisis to calm. J Health Commun 2005;10(2):103-104.
25. Shore DA. Communicating in times of uncertainty: the need for trust. J Health Commun 2003;8(Suppl 1):13-14.
26. Sorensen J. Risk communication and terrorism. Biosecur Bioterror 2004;2(3):229-231.
27. The Working Group on ''Governance Dilemmas'' in Bioterrorism Response. Leading during bioattacks and epidemics with the public's trust and help. Biosecur Bioterror 2004;2(1):25-40.
28. Peters RG, Covello VT, McCallum DB. The determinants of trust and credibility in environmental risk communication: an empirical study. Risk Anal 1997;17(1):43-54.
29. Trettin L, Musham C. Is trust a realistic goal of environmental risk communication? Environ Behav 2000;32(3):410-426.
30. Kindy K, Connolly C. US may add shots for swine flu to fall regimen. Washington Post May 6, 2009.
31. Stein R, Kindy K. New virus appears to be a factor in extended flu season. Washington Post May 16, 2009.
32. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 2009;361(2):112-115.
33. U.S. Department of Health and Human Services. HHS 2009 H1N1 Vaccine Development Activities. 2009. https:==www.medicalcountermeasures.gov=BARDA=MCM= panflu=factsheet.aspx. Accessed September 11, 2009.
34. Supply and safety issues surrounding an H1N1 vaccine [editorial]. Lancet 2009;374(9687):358.
35. Cohen J. Laurie Garrett interview: U.S. global health leader MIA on swine flu. ScienceInsider July 28, 2009. http:== blogs.sciencemag.org=scienceinsider= 2009=07=laurie-garrett. html. Accessed September 11, 2009.
36. Cheng M. Novartis starts testing swine flu vaccine. Washington Post August 5, 2009.
37. Kindy K. 1976 swine flu response haunts health officials. Washington Post May 8, 2009.
38. Pollack A. Fear of a swine flu epidemic in 1976 offers some lessons, and concerns, today. New York Times May 9, 2009.
39. Knowledge Networks KnowledgePanel 2009. http:== www.knowledgenetworks. com=knpanel=index.html. Accessed September 11, 2009.
40. Knowledge Networks. Government and Academic Research. 2009. http:==www.knowledgenetworks.com=ganp=. Accessed September 11, 2009.
41. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization of Tamiflu (oseltamivir). 2009. http:==www.cdc.gov=h1n1flu=eua= tamiflu.htm. Accessed September 11, 2009.
42. Meredith LS, Eisenman DP, Rhodes H, Ryan G, Long A. Trust influences response to public health messages during a bioterrorist event. J Health Commun 2007;12(3):217-232.
43. SAS 9.1.3 Help and Documentation. 2002-2004. Cary, NC: SAS Institute Inc.
44. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q 1984;11(1):1-47.
45. U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. Novel H1N1 Vaccination Recommendations. 2009. http:==www.cdc.gov= h1n1flu=vaccination=acip.htm. Accessed September 11, 2009.
46. Sandman PM. Pandemics: good hygiene is not enough. Nature 2009;459(7245):322-323.
47. Cummings KM, Jette AM, Brock BM, Haefner DP. Psychosocial determinants of immunization behavior in a swine influenza campaign. Med Care 1979;17(6):639.
48. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization of Relenza (zanamivir). 2009. http:==www.cdc.gov=h1n1flu=eua= relenza.htm. Accessed September 11, 2009.
49. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization of N95 Respirators. 2009. http:==www. cdc.gov=h1n1flu=eua=n95.htm. Accessed September 11, 2009.
50. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization of rRT-PCR Flu Panel (NPS, NS, TS, NPS=TS, NA). 2009. http:==www.cdc.gov=h1n1flu= eua=rRT-PCR-flu-panel.htm. Accessed September 11, 2009.
51. U.S. Centers for Disease Control and Prevention. Emergency Use Authorization of rRT-PCR Swine Flu Panel. 2009. http:==www.cdc.gov=h1n1flu=eua= testkit.htm. Accessed September 11, 2009.
52. Tang CS, Wong CY. An outbreak of the severe acute respiratory syndrome: predictors of health behaviors and effect of community prevention measures in Hong Kong, China. Am J Public Health 2003;93(11):1887-1888.
53. Rubin GJ, Amlôt R, Page L, Wessely S. Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: cross sectional telephone survey. BMJ 2009;339: b2651.
54. Freimuth VS, Quinn SC, Thomas SB, Cole G, Zook E, Duncan T. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med 2001;52(5):797-808.
55. Thomas SB, Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. Am J Public Health 1991;81(11):1498-1505.
56. Quinn S. Crisis and emergency risk communication in a pandemic: a model for building capacity and resilience of minority communities. Health Promot Pract 2008;9(4): 18S-25S.
57. Neergard L. US: 160M doses of swine flu vaccine due in Oct. Washington Post July 24, 2009.